| (USD) | Jun 2026 | Y/Y change |
|---|---|---|
| Revenue | 10.13M | — |
| Operating expense | — | — |
| Net income | -40.62M | — |
| Net profit margin | — | — |
| Earnings per share | — | — |
| EBITDA | — | — |
| Effective tax rate | — | — |
Over the past year, NKTR returned +172.6% with dividends reinvested.
| Period | Total return |
|---|---|
| YTD | +74.3% |
| 1 year | +172.6% |
| 5 years | -68.3% |
| 10 years | -72.5% |
| All-time high | $1,593.90 (Mar 2018) |
Returns are total returns and include reinvested dividends. The all-time high is the highest monthly closing price on record.
See what $1,000 in NKTR would be worth today ›No. Nektar Therapeutics has not paid a dividend in the past 12 months.
Nektar Therapeutics stock trades on NASDAQ under the ticker symbol NKTR.
Nektar Therapeutics is part of the Healthcare sector.
Nektar Therapeutics has a market cap of 2.52B USD, based on the latest quote.
Nektar Therapeutics is expected to report earnings around Nov 12, 2026. That date is an estimate and has not been confirmed by the company.
